{
    "clinical_study": {
        "@rank": "112568", 
        "arm_group": [
            {
                "arm_group_label": "gluten", 
                "arm_group_type": "Active Comparator", 
                "description": "10 grams of gluten in each sachet to be dispersed daily on food for ten days, while maintaining a gluten free diet"
            }, 
            {
                "arm_group_label": "gluten free flour", 
                "arm_group_type": "Placebo Comparator", 
                "description": "10 grams of gluten free flour in each sachet to be dispersed daily on food for ten days, while maintaining a gluten free diet"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the prevalence of Gluten Sensitivity, by a\n      double-blind placebo-controlled challenge with gluten, followed by two months period of\n      Low-FODMAPs (Fermentable Oligosaccharides Disaccharides Monosaccharides And Polyols) diet,\n      in patients spontaneously adherent to gluten free diet because of symptoms upon gluten\n      exposure and in whom diagnosis of Celiac Disease and Wheat Allergy has been ruled out."
        }, 
        "brief_title": "Prevalence of Non Celiac Gluten Sensitivity Among Patients Spontaneously Adherent to Gluten Free Diet", 
        "condition": "Non Celiac Gluten Sensitivity", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adherence to gluten free diet without medical need\n\n          -  Negative Celiac Disease related serology (while on gluten containing diet)\n\n          -  Normal villous structure at duodenal biopsy (while on gluten containing diet)\n\n        Exclusion Criteria:\n\n          -  Diagnosis of Celiac Disease\n\n          -  Diagnosis of Wheat Allergy\n\n          -  Diagnosis of organic gastrointestinal disease\n\n          -  Severe concomitant disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "26", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01827566", 
            "org_study_id": "GE-2012-GS"
        }, 
        "intervention": [
            {
                "arm_group_label": "gluten", 
                "intervention_name": "gluten", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "gluten free flour", 
                "intervention_name": "gluten free flour", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Celiac Disease", 
            "Gluten Sensitivity", 
            "Gluten", 
            "Double-blind challenge, placebo-controlled challenge"
        ], 
        "lastchanged_date": "June 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Brescia", 
                    "country": "Italy", 
                    "zip": "I-25123"
                }, 
                "name": "University and Spedali Civili of Brescia, Unit of Gastroenterology"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial With a Cross-over Design to Assess the Prevalence of Non Celiac Gluten Sensitivity Among Patients Spontaneously Adherent to Gluten Free Diet", 
        "overall_official": [
            {
                "affiliation": "University of Brescia, Unit of Gastroenterology", 
                "last_name": "Alberto Lanzini, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University of Brescia, Unit of Gastroenterology", 
                "last_name": "Barbara Zanini, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Brescia, Unit of Gastroenterology", 
                "last_name": "Chiara Ricci, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "time 0: start of first challenge (phase A, either with gluten or gluten free flour)\ntime 10: end of phase A and start of wash-out period\ntime 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)\ntime 35: end of phase B", 
            "measure": "Patient's ability to correctly identify the phase with gluten", 
            "safety_issue": "No", 
            "time_frame": "Time (days)  35"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01827566"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universit\u00e0 degli Studi di Brescia", 
            "investigator_full_name": "Alberto Lanzini, MD PhD", 
            "investigator_title": "Associate Professor of Gastroenterology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "time 0: start of first challenge (phase A, either with gluten or gluten free flour)\ntime 10: end of phase A and start of wash-out period\ntime 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)\ntime 35: end of phase B", 
                "measure": "Changes in serum level of anti-tissue transglutaminases immunoglobulin A (IgA)/immunoglobulin G (IgG) and of anti-gliadin IgA/IgG", 
                "safety_issue": "No", 
                "time_frame": "Time (days) 0, 10, 25, 35"
            }, 
            {
                "description": "time 0: start of first challenge (phase A, either with gluten or gluten free flour)\ntime 10: end of phase A and start of wash-out period\ntime 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)\ntime 35: end of phase B", 
                "measure": "Change in Fatigue Visual Scale", 
                "safety_issue": "No", 
                "time_frame": "Time (days) 0, 10, 25, 35"
            }, 
            {
                "description": "Time 0: Start of first challenge (phase A, either with gluten or gluten free flour)\nTime 10: end of phase A and start of wash-out period\nTime 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)\nTime 35: end of phase B\nAt the beginning of Low-FODMAPs diet\nAfter two months of Low-FODMAPs diet", 
                "measure": "Change in Gastrointestinal Rating Score (GSRS) during Challenge with and without gluten", 
                "safety_issue": "Yes", 
                "time_frame": "Time (days) 0,10, 25, 35"
            }, 
            {
                "description": "time 0: start of first challenge (phase A, either with gluten or gluten free flour)\ntime 10: end of phase A and start of wash-out period\ntime 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)\ntime 35: end of phase B", 
                "measure": "Change in symptoms' score (1 to 7 Likert scale) as recorded on a daily diary", 
                "safety_issue": "No", 
                "time_frame": "From Time 0 (days) to 10 and from 25 to 35"
            }
        ], 
        "source": "Universit\u00e0 degli Studi di Brescia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universit\u00e0 degli Studi di Brescia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}